Charles Schwab Investment Management Inc Monte Rosa Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$601 Billion
Q3 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 383,268 shares of GLUE stock, worth $5.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

383,268

Previous 381,337 0.51%

Holding current value

$5.5 Million

Previous $1.72 Million 65.21%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	BUY	$4.19 - $7.49 $8,090 - $14,463	1,931 Added 0.51%	383,268 $2.84 Million
Q2 2025 Aug 12, 2025	BUY	$3.7 - $5.33 $73,267 - $105,544	19,802 Added 5.48%	381,337 $1.72 Million
Q1 2025 Sep 15, 2025	SELL	$4.64 - $7.17 $91,881 - $141,980	-19,802 Reduced 5.19%	361,535 $1.68 Million
Q1 2025 May 09, 2025	SELL	$4.64 - $7.17 $41,467 - $64,078	-8,937 Reduced 2.41%	361,535 $1.68 Million
Q4 2024 Feb 06, 2025	BUY	$4.8 - $10.36 $115,075 - $248,370	23,974 Added 6.92%	370,472 $2.57 Million

Q3 2024 Nov 12, 2024	BUY	$3.59 - $6.97 $124,565 - $241,845	34,698 Added 11.13%	346,498 $1.84 Million
Q2 2024 Aug 12, 2024	BUY	$3.38 - $7.86 $206,916 - $481,173	61,218 Added 24.43%	311,800 $1.17 Million
Q1 2024 May 08, 2024	BUY	$4.26 - $8.46 $21,385 - $42,469	5,020 Added 2.04%	250,582 $1.77 Million
Q4 2023 Feb 06, 2024	BUY	$2.5 - $5.93 $7,672 - $18,199	3,069 Added 1.27%	245,562 $1.39 Million
Q3 2023 Nov 08, 2023	BUY	$4.78 - $7.22 $58,674 - $88,625	12,275 Added 5.33%	242,493 $1.16 Million
Q2 2023 Aug 09, 2023	BUY	$4.53 - $8.4 $26,418 - $48,988	5,832 Added 2.6%	230,218 $1.58 Million
Q1 2023 May 11, 2023	SELL	$5.95 - $8.21 $583 - $804	-98 Reduced 0.04%	224,386 $1.75 Million
Q4 2022 Feb 13, 2023	BUY	$6.71 - $9.72 $75,614 - $109,534	11,269 Added 5.29%	224,484 $1.71 Million
Q3 2022 Nov 14, 2022	BUY	$7.17 - $12.16 $695,353 - $1.18 Million	96,981 Added 83.44%	213,215 $1.74 Million
Q2 2022 Aug 15, 2022	SELL	$6.15 - $14.99 $56,370 - $137,398	-9,166 Reduced 7.31%	116,234 $1.12 Million
Q1 2022 May 13, 2022	BUY	$10.36 - $20.41 $417,901 - $823,298	40,338 Added 47.42%	125,400 $1.76 Million
Q4 2021 Feb 11, 2022	BUY	$16.28 - $27.15 $82,832 - $138,139	5,088 Added 6.36%	85,062 $1.74 Million
Q3 2021 Nov 16, 2021	BUY	$18.59 - $42.21 $1.49 Million - $3.38 Million	79,974 New	79,974 $1.78 Million

Others Institutions Holding GLUE

# of Institutions

133

Shares Held

55.7M

Call Options Held

159K

Put Options Held

269K

View Full List

About Monte Rosa Therapeutics, Inc.

Ticker GLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,713,900
Market Cap $671M
Description
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...

More about GLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Monte Rosa Therapeutics, Inc. Transaction History